| Metabolic syndrome and its association with colorectal cancer: a review. | |
| | |
MedLine Citation:
|
PMID: 20460980 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Currently, significant amount of epidemiologic evidence is present to suggest that metabolic syndrome increases the risk of developing colorectal cancer. This evidence is based on studies of the evaluate determinants of the metabolic syndrome (obesity), clinical consequences of metabolic syndrome (type 2 diabetes and hypertension) and serum component of metabolic syndrome (hypertriglyceridemia, hyperglycemia and low high-density lipoprotein cholesterol), as well as markers of hyperinsulinemia. Although the exact pathogenesis of this relationship is unknown, it seems that hyperinsulinemia may play a pivotal role in increasing CRC risk. |
| | |
Authors:
|
Ali A Siddiqui |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The American journal of the medical sciences Volume: 341 ISSN: 1538-2990 ISO Abbreviation: Am. J. Med. Sci. Publication Date: 2011 Mar |
Date Detail:
|
Created Date: 2011-02-23 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0370506 Medline TA: Am J Med Sci Country: United States |
Other Details:
|
Languages: eng Pagination: 227-31 Citation Subset: AIM; IM |
Affiliation:
|
From the Department of Internal Medicine, Dallas Veterans Affairs Medical Center, and Division of Gastroenterology and Hepatology, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas. Submitted March 16, 2010; accepted in revised form March 24, 2010. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Somali Bantu refugees in southwest Idaho: assessment using participatory research.
Next Document: Influence of Cinnamaldehyde on Viral Myocarditis in Mice.